( December 22, 2015, 04:06 GMT | Official Statement) -- MLex Summary: The Chongqing municipal branch of the State Administration for Industry and Commerce has fined Chongqing Qingyang Pharmaceuticals 439,308.53 yuan ($68,000), or 3 percent of its 2013 revenue, for abuses of market dominance, SAIC said today. An investigation found that Qingyang Pharmaceuticals had stopped supplying allopurinol ingredients to its distributors and other manufacturers of allopurinol for half a year in order to raise the prices of the ingredients and increase its share of the allopurinol market. The order follows:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.